Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

01-12-2020 | Diabetic Nephropathy | Research article

Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function

Authors: Yun-Yun He, Zhe Chen, Xiang-Yang Fang, Jing Chang, Yong Lu, Xiao-Juan Wang

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Background

Albuminuria is the early manifestation of the pathogenesis of diabetic nephropathy (DN). The current study was to investigate the relationship of pulmonary function with albuminuria in type 2 diabetic patients with preserved renal function to evaluate the role of pulmonary function in the early stage of DN.

Methods

A total of 326 patients with type 2 diabetes mellitus (T2DM) including 270 without albuminuria and 56 with albuminuria, and 265 non-diabetic patients were enrolled. The patients’ general information, and the parameters of pulmonary function, including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC, total lung capacity (TLC), diffusion capacity for carbon monoxide of lung (DLCO) were compared between T2DM and control groups, as well as T2DM patients with and without albuminuria groups. All pulmonary function parameters were expressed as a percentage of those predicted (%pred). Logistic regression models were constructed to test the association of albuminuria and pulmonary function.

Results

The values of FVC%pred, FEV1%pred, TLC%pred and DLCO%pred were lower, and the proportion of subjects with FVC%pred < 80, FEV1%pred < 80, and DLCOc%pred < 80 was higher in T2DM subjects than controls (all P < 0.05). Subgroup analysis of diabetic patients showed that the values of FVC%pred, FEV1%pred, TLC%pred, and DLCOc%pred (97.18 ± 13.45, 93.95 ± 14.51, 90.64 ± 9.97, 87.27 ± 13.13, respectively) were significantly lower in T2DM subjects with albuminuria than those without albuminuria (103.94 ± 14.12, 99.20 ± 14.25, 93.79 ± 10.36, 92.62 ± 13.45, all P < 0.05). There was a significantly negative correlation between the urine albumin-to-creatinine ratio (UACR) and DLCOc%pred (r = − 0.143, P = 0.010) in spearman linear correlation test. In logistic regression analysis, the FVC%pred (OR 0.965, 95%CI 0.944–0.988), FEV1%pred (OR 0.975, 95%CI 0.954–0.996), and DLCOc%pred (OR 0.974, 95%CI 0.951–0.998) were independently associated with albuminuria after adjustments for smoking index, duration, HbA1c, FBG, and TG.

Conclusion

Our results demonstrated albuminuria is associated with a restrictive pulmonary function as well as pulmonary diffusion function in T2DM with preserved renal function, which remind us to be alert of the pulmonary function decline even in the early stage of DN.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sampol G, Lecube A. Type 2 diabetes and the lung: a bidirectional relationship. Endocrinol Nutr. 2012;59(2):95–7.CrossRef Sampol G, Lecube A. Type 2 diabetes and the lung: a bidirectional relationship. Endocrinol Nutr. 2012;59(2):95–7.CrossRef
2.
go back to reference Ramirez LC, Dal Nogare A, Hsia C, Arauz C, Butt I, Strowig SM, Schnurr-Breen L, Raskin P. Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. Am J Med. 1991;91(4):371–6.CrossRef Ramirez LC, Dal Nogare A, Hsia C, Arauz C, Butt I, Strowig SM, Schnurr-Breen L, Raskin P. Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. Am J Med. 1991;91(4):371–6.CrossRef
3.
go back to reference Benbassat CA, Stern E, Kramer M, Lebzelter J, Blum I, Fink G. Pulmonary function in patients with diabetes mellitus. Am J Med Sci. 2001;322(3):127–32.CrossRef Benbassat CA, Stern E, Kramer M, Lebzelter J, Blum I, Fink G. Pulmonary function in patients with diabetes mellitus. Am J Med Sci. 2001;322(3):127–32.CrossRef
4.
go back to reference Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE, Selvin E, Brancati FL. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2008;31(4):741–6.CrossRef Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE, Selvin E, Brancati FL. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2008;31(4):741–6.CrossRef
5.
go back to reference Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle diabetes study. Diabetes Res Clin Pract. 2000;50(2):153–9.CrossRef Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle diabetes study. Diabetes Res Clin Pract. 2000;50(2):153–9.CrossRef
6.
go back to reference Sonoda N, Morimoto A, Tatsumi Y, Asayama K, Ohkubo T, Izawa S, Ohno Y. A prospective study of the impact of diabetes mellitus on restrictive and obstructive lung function impairment: the Saku study. Metabolism. 2018;82:58–64.CrossRef Sonoda N, Morimoto A, Tatsumi Y, Asayama K, Ohkubo T, Izawa S, Ohno Y. A prospective study of the impact of diabetes mellitus on restrictive and obstructive lung function impairment: the Saku study. Metabolism. 2018;82:58–64.CrossRef
7.
go back to reference Kishore L, Kaur N, Singh R. Distinct biomarkers for early diagnosis of diabetic nephropathy. Curr Diabetes Rev. 2017;13(6):598–605.CrossRef Kishore L, Kaur N, Singh R. Distinct biomarkers for early diagnosis of diabetic nephropathy. Curr Diabetes Rev. 2017;13(6):598–605.CrossRef
8.
go back to reference Miyake H, Kanazawa I, Sugimoto T. Albuminuria increases all-cause mortality in Japanese patients with type 2 diabetes mellitus. J Clin Med. 2018;7(9):234.CrossRef Miyake H, Kanazawa I, Sugimoto T. Albuminuria increases all-cause mortality in Japanese patients with type 2 diabetes mellitus. J Clin Med. 2018;7(9):234.CrossRef
9.
go back to reference Yoon JH, Won JU, Ahn YS, Roh J. Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and nutrition examination survey. PLoS One. 2014;9(4):e94125.CrossRef Yoon JH, Won JU, Ahn YS, Roh J. Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and nutrition examination survey. PLoS One. 2014;9(4):e94125.CrossRef
10.
go back to reference Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S. Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease. The NHLBI pooled cohorts study. Am J Respir Crit Care Med. 2019;199(3):321–32.CrossRef Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S. Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease. The NHLBI pooled cohorts study. Am J Respir Crit Care Med. 2019;199(3):321–32.CrossRef
11.
go back to reference Nakade Y, Toyama T, Furuichi K, Kitajima S, Ohkura N, Sagara A, Shinozaki Y, Hara A, Kitagawa K, Shimizu M, Iwata Y, Oe H, Nagahara M, Horita H, Sakai Y, Kaneko S, Wada T. Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2014;18(5):763–9.CrossRef Nakade Y, Toyama T, Furuichi K, Kitajima S, Ohkura N, Sagara A, Shinozaki Y, Hara A, Kitagawa K, Shimizu M, Iwata Y, Oe H, Nagahara M, Horita H, Sakai Y, Kaneko S, Wada T. Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2014;18(5):763–9.CrossRef
12.
go back to reference De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant. 2014;29(3):657–62.CrossRef De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R. Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant. 2014;29(3):657–62.CrossRef
13.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRef
14.
go back to reference Pulmonary function professional group of respiratory branch of Chinese medical association. Guidelines for lung function test (Part II) - spirometry examination. Chin J Tuberc Respir Dis. 2014;37(7):481–6. Pulmonary function professional group of respiratory branch of Chinese medical association. Guidelines for lung function test (Part II) - spirometry examination. Chin J Tuberc Respir Dis. 2014;37(7):481–6.
15.
go back to reference Pulmonary function professional group of respiratory branch of Chinese medical association. Guidelines for lung function test - lung diffusion function examination. Chin J Tuberc Respir Dis. 2015;38(3):164–9. Pulmonary function professional group of respiratory branch of Chinese medical association. Guidelines for lung function test - lung diffusion function examination. Chin J Tuberc Respir Dis. 2015;38(3):164–9.
16.
go back to reference Lecube A, Simo R, Pallayova M, Punjabi NM, Lopez-Cano C, Turino C, Hernandez C, Barbe F. Pulmonary function and sleep breathing: two new targets for type 2 diabetes care. Endocr Rev. 2017;38(6):550–73.CrossRef Lecube A, Simo R, Pallayova M, Punjabi NM, Lopez-Cano C, Turino C, Hernandez C, Barbe F. Pulmonary function and sleep breathing: two new targets for type 2 diabetes care. Endocr Rev. 2017;38(6):550–73.CrossRef
17.
go back to reference Pitocco D, Fuso L, Conte EG, Zaccardi F, Condoluci C, Scavone G, Incalzi RA, Ghirlanda G. The diabetic lung--a new target organ? Rev Diabet Stud. 2012;9(1):23–35.CrossRef Pitocco D, Fuso L, Conte EG, Zaccardi F, Condoluci C, Scavone G, Incalzi RA, Ghirlanda G. The diabetic lung--a new target organ? Rev Diabet Stud. 2012;9(1):23–35.CrossRef
18.
go back to reference Klein OL, Kalhan R, Williams MV, Tipping M, Lee J, Peng J, Smith LJ. Lung spirometry parameters and diffusion capacity are decreased in patients with type 2 diabetes. Diabet Med. 2012;29(2):212–9.CrossRef Klein OL, Kalhan R, Williams MV, Tipping M, Lee J, Peng J, Smith LJ. Lung spirometry parameters and diffusion capacity are decreased in patients with type 2 diabetes. Diabet Med. 2012;29(2):212–9.CrossRef
19.
go back to reference Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, Hsia CC. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care. 2008;31(8):1596–601.CrossRef Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P, Hsia CC. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care. 2008;31(8):1596–601.CrossRef
20.
go back to reference Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and type 2 diabetes mellitus. Diabet Med. 2010;27(9):977–87.CrossRef Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and type 2 diabetes mellitus. Diabet Med. 2010;27(9):977–87.CrossRef
21.
go back to reference Kopf S, Groener JB, Kender Z, Fleming T, Brune M, Riedinger C, Volk N, Herpel E, Pesta D, Szendrodi J, Wielputz MO, Kauczor HU, Katus HA, Kreuter M, Nawroth PP. Breathlessness and restrictive lung disease. An important diabetes-related feature in patients with type 2 diabetes. Respiration. 2018;96(1):29–40.CrossRef Kopf S, Groener JB, Kender Z, Fleming T, Brune M, Riedinger C, Volk N, Herpel E, Pesta D, Szendrodi J, Wielputz MO, Kauczor HU, Katus HA, Kreuter M, Nawroth PP. Breathlessness and restrictive lung disease. An important diabetes-related feature in patients with type 2 diabetes. Respiration. 2018;96(1):29–40.CrossRef
22.
go back to reference Sanchez E, Gutierrez-Carrasquilla L, Barbe F, Betriu A, Lopez-Cano C, Gaeta AM, Purroy F, Pamplona R, Ortega M, Fernandez E, Hernandez C, Lecube A, Simo R. Lung function measurements in the prediabetes stage: data from the ILERVAS Project. Acta Diabetol. 2019;56(9):1005–12.CrossRef Sanchez E, Gutierrez-Carrasquilla L, Barbe F, Betriu A, Lopez-Cano C, Gaeta AM, Purroy F, Pamplona R, Ortega M, Fernandez E, Hernandez C, Lecube A, Simo R. Lung function measurements in the prediabetes stage: data from the ILERVAS Project. Acta Diabetol. 2019;56(9):1005–12.CrossRef
23.
go back to reference Saler T, Cakmak G, Saglam ZA, Ataoglu E, Yesim Erdem T, Yenigun M. The assessment of pulmonary diffusing capacity in diabetes mellitus with regard to microalbuminuria. Intern Med. 2009;48(22):1939–43.CrossRef Saler T, Cakmak G, Saglam ZA, Ataoglu E, Yesim Erdem T, Yenigun M. The assessment of pulmonary diffusing capacity in diabetes mellitus with regard to microalbuminuria. Intern Med. 2009;48(22):1939–43.CrossRef
24.
go back to reference Anandhalakshmi S, Manikandan S, Ganeshkumar P, Ramachandran C. Alveolar gas exchange and pulmonary functions in patients with Type II diabetes mellitus. J Clin Diagn Res. 2013;7(9):1874–7. Anandhalakshmi S, Manikandan S, Ganeshkumar P, Ramachandran C. Alveolar gas exchange and pulmonary functions in patients with Type II diabetes mellitus. J Clin Diagn Res. 2013;7(9):1874–7.
25.
go back to reference Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease. Challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–45.CrossRef Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease. Challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–45.CrossRef
26.
go back to reference Lee K. Lung function and impaired kidney function in relation to metabolic syndrome. Int Urol Nephrol. 2017;49(7):1217–23.CrossRef Lee K. Lung function and impaired kidney function in relation to metabolic syndrome. Int Urol Nephrol. 2017;49(7):1217–23.CrossRef
27.
go back to reference Mukai H, Ming P, Lindholm B, Heimburger O, Barany P, Stenvinkel P, Qureshi AR. Lung dysfunction and mortality in patients with chronic kidney disease. Kidney Blood Press Res. 2018;43(2):522–35.CrossRef Mukai H, Ming P, Lindholm B, Heimburger O, Barany P, Stenvinkel P, Qureshi AR. Lung dysfunction and mortality in patients with chronic kidney disease. Kidney Blood Press Res. 2018;43(2):522–35.CrossRef
28.
go back to reference Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K. Lung function and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;70(5):675–85.CrossRef Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K. Lung function and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;70(5):675–85.CrossRef
29.
go back to reference Roberts TJ, Burns AT, MacIsaac RJ, MacIsaac AI, Prior DL, La Gerche A. Diagnosis and significance of pulmonary microvascular disease in diabetes. Diabetes Care. 2018;41(4):854–61.CrossRef Roberts TJ, Burns AT, MacIsaac RJ, MacIsaac AI, Prior DL, La Gerche A. Diagnosis and significance of pulmonary microvascular disease in diabetes. Diabetes Care. 2018;41(4):854–61.CrossRef
30.
go back to reference Agarwal AS, Fuladi AB, Mishra G, Tayade BO. Spirometry and diffusion studies in patients with type-2 diabetes mellitus and their association with microvascular complications. Ind J Chest Dis Allied Sci. 2010;52(4):213–6. Agarwal AS, Fuladi AB, Mishra G, Tayade BO. Spirometry and diffusion studies in patients with type-2 diabetes mellitus and their association with microvascular complications. Ind J Chest Dis Allied Sci. 2010;52(4):213–6.
31.
go back to reference Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med. 2005;118(3):205–11.CrossRef Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med. 2005;118(3):205–11.CrossRef
32.
go back to reference Tai H, Wang MY, Zhao YP, Li LB, Jiang XL, Dong Z, Lv XN, Liu J, Dong QY, Liu XG, Kuang JS. Pulmonary function and retrobulbar hemodynamics in subjects with type 2 diabetes mellitus. Respir Care. 2017;62(5):602–14.CrossRef Tai H, Wang MY, Zhao YP, Li LB, Jiang XL, Dong Z, Lv XN, Liu J, Dong QY, Liu XG, Kuang JS. Pulmonary function and retrobulbar hemodynamics in subjects with type 2 diabetes mellitus. Respir Care. 2017;62(5):602–14.CrossRef
Metadata
Title
Relationship between pulmonary function and albuminuria in type 2 diabetic patients with preserved renal function
Authors
Yun-Yun He
Zhe Chen
Xiang-Yang Fang
Jing Chang
Yong Lu
Xiao-Juan Wang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00598-1

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue